CJC-1295
peptideoften paired with Ipamorelin
Growth-hormone secretagogue (GHRH analog)
Research status · Not FDA-approved
Not FDA-approved for human use. Reached early-phase research only; available (where legal) via compounding pharmacies. Regulatory status shifted during 2025–2026 FDA compounding review — verify current status.
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH) discussed in recovery, sleep, and body-composition contexts, frequently paired with ipamorelin. It is not an approved medication; human evidence is limited.
How it works
Mimics GHRH to stimulate the pituitary to release the body's own growth hormone, indirectly raising GH and IGF-1.
Commonly discussed use cases
- Recovery (discussed)
- Sleep quality (discussed)
- Body composition (discussed)
Supposed / potential benefits
- Reported subjective improvements in sleep/recovery in communities — not established in large trials
Common side effects
- Water retention
- Tingling/numbness
- Headache
- Injection-site reactions
- Possible blood-sugar changes
Warnings & contraindications
- Not FDA-approved; long-term safety not established
- Raising GH/IGF-1 has theoretical risks (e.g., glucose effects, potential to affect growth of existing tumors) — a clinician-level discussion
- Unregulated products carry purity/dosing risks
Typical timing considerations
Community/clinic discussions often mention dosing away from meals and around sleep; only a clinician should direct this.
Administration route
Subcutaneous injection
Storage
Peptides are typically refrigerated after reconstitution; follow clinician/compounding-pharmacy instructions.
Questions to ask your clinician
- What baseline labs (IGF-1, glucose) would you want before and during?
- How would we judge benefit vs risk objectively?
- What would make you stop this?
Commonly tracked in Reta
Tracking fields organize user-entered, clinician-directed routines — Reta never recommends or computes doses.
Track this in Reta
Beta members get a ready-made tracker for CJC-1295 — schedule, dose log, injection-site rotation, reminders, and check-ins — for organizing a clinician-directed routine. Personal tracking is available to everyone during the Public Beta.
Reta is a tracking and education tool — not a medical provider. Nothing here is a diagnosis, treatment, prescription, or dosing recommendation. Peptides and medications should only be used under the direction of a licensed clinician. Talk to a qualified clinician before starting, stopping, combining, or changing anything. Many compounds below are not FDA-approved for human use; some are investigational or sold through unregulated channels where purity and dosing are not guaranteed.